PSA vs SXTPW
PSA (PSA) versus 60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) is a biotechnology company listed on NASDAQ.
Latest reported PSA revenue for 2026-06-30 was $1.23B. Net income was $500.0M. Revenue was up 1.2% from 2026-03-31 to 2026-06-30. PSA currently screens at market cap $0.
SXTPW does not have a complete income-statement cache yet.
PSA currently screens at market cap $0. SXTPW currently screens at market cap $0.
Not investment advice. Open the PSA and SXTPW stock pages for the full models.
Not investment advice.